Unstated is that if a malaria drug can turn alpha cells into insulin producing beta cells, there’s probably some other drug or compound that does the opposite.
There are many substances that can incite the immune system against the body, yes, and certainly some of them will help cause type 1 diabetes. What is needed is several of the means by which the body ameliorates these attacks.
One is the two proteins that most people make every day, in their new tissues, that keep the immune system at bay. One of them, when a white blood cell attacks new tissue, causes the cell to undergo “apoptosis”, ….it self-destructs, before it can designate the new tissue as foreign to the rest of the immune system. The other protein picks up glyco-proteins from the surface of cells in the new tissue, and carts them off to the spleen, where it basically says “These are good guys, dinna fash them!” These 2 proteins were identified bout 10 years ago. But the FDA requires that, in spite of most people making them in their body every day, they go through the full scope of trials before being used to treat type 1 diabetes, with all the funding needed, and since they are made every day in most people’s bodies, no possibility of patenting them.
Another way to keep these new beta cells from being attacked by the immune system that killed the old ones is to reset the immune system by a high dose of Bcg tuberculosis vaccine, first approved by the FDA in 1909. This has got through Phase 1. But, you guessed it, the FDA is still requiring all the far more expensive Phase 2 and phase 3 testing, with no possibility of patents to let investors pay for the testing.
Unstated is that if a malaria drug can turn alpha cells into insulin producing beta cells, there’s probably some other drug or compound that does the opposite.
There are many substances that can incite the immune system against the body, yes, and certainly some of them will help cause type 1 diabetes. What is needed is several of the means by which the body ameliorates these attacks.
One is the two proteins that most people make every day, in their new tissues, that keep the immune system at bay. One of them, when a white blood cell attacks new tissue, causes the cell to undergo “apoptosis”, ….it self-destructs, before it can designate the new tissue as foreign to the rest of the immune system. The other protein picks up glyco-proteins from the surface of cells in the new tissue, and carts them off to the spleen, where it basically says “These are good guys, dinna fash them!” These 2 proteins were identified bout 10 years ago. But the FDA requires that, in spite of most people making them in their body every day, they go through the full scope of trials before being used to treat type 1 diabetes, with all the funding needed, and since they are made every day in most people’s bodies, no possibility of patenting them.
Another way to keep these new beta cells from being attacked by the immune system that killed the old ones is to reset the immune system by a high dose of Bcg tuberculosis vaccine, first approved by the FDA in 1909. This has got through Phase 1. But, you guessed it, the FDA is still requiring all the far more expensive Phase 2 and phase 3 testing, with no possibility of patents to let investors pay for the testing.
This is how the FDA is killing diabetics.